Exabis Library
Welcome to the e-CCO Library!
OP05: Crohn’s disease exclusion diet is equally effective but better tolerated than exclusive enteral nutrition for induction of remission in mild-to-moderate active paediatric Crohn’s disease: a prospective randomised controlled trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP05: High-dimensional single-cell analysis identifies cellular signatures associated with response to vedolizumab therapy in ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP05: Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP06 Comparison between Crohn and coeliac diseases small intestine transcriptomics and microbial data define similarities and divergent pathways linked to pathogenesis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP06: 5-aminosalicylates are not associated with adverse outcomes in Inflammatory Bowel Disease patients with COVID-19: Analysis from an international registry
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP06: Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP06: Multiomic interrogation of the epithelium in active Ulcerative Colitis reveals dysregulated myeloid cells associated with non-response to anti-Tumour Necrosis Factor therapy.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP06: The influence of different prednisolone tapering algorithms on the effectiveness of infliximab in patients with Ulcerative Colitis – A real-world cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP07 The epidemiology of inflammatory bowel diseases among immigrants to Denmark: A population-based cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP07: Absolute and relative risks of kidney and urological complications in patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairment
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP07: Artificial intelligence surpasses gastrointestinal experts in the classification of endoscopic severity among Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP07: Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP08 Inflammatory bowel disease and risk of small bowel cancer: A binational population-based cohort study from Denmark and Sweden
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP08: Automatic detection of enteric ulcers and erosions in capsule endoscopy using a convolutional neural network
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP08: Long-term efficacy and pharmacodynamics of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) monoclonal antibody SHP647 in Crohn’s disease: the OPERA II study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP08: Mucosal healing with vedolizumab in inflammatory bowel disease patients with chronic pouchitis: Evidence from EARNEST, a randomized, double-blind, placebo-controlled trial
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP08: The effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 U-ACHIEVE maintenance results
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP09 Immunomodulatory mechanisms of faecal microbiota transplantation are associated with clinical response in ulcerative colitis: early results from STOP-Colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP09: Histological remission and mucosal healing in a randomised, placebo-controlled, Phase 2 study of etrasimod in patients with moderately to severely active ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM